---
title: "SL PHARM (002038.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002038.SZ/norm.md"
symbol: "002038.SZ"
name: "SL PHARM"
parent: "https://longbridge.com/en/quote/002038.SZ.md"
datetime: "2026-03-11T23:22:10.751Z"
locales:
  - [en](https://longbridge.com/en/quote/002038.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002038.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002038.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002038.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002038.SZ/norm.md)


# SL PHARM (002038.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0188 | 0.0865 | 0.0400 | -0.0498 | -0.0418 |
| ROE | 1.41% | 5.31% | 3.29% | -4.09% | -3.23% |
| Revenue | 153.89M | 135.96M | 168.90M | 119.86M | 148.50M |
| Net income | 20.05M | 75.08M | 45.97M | -57.33M | -46.33M |
| Operating income | 2.26M | 3.74M | 11.95M | -31.50M | -53.06M |
| Gross margin | 59.35% | 67.03% | 59.27% | 65.54% | 45.52% |
| Net margin | 13.03% | 55.22% | 27.22% | -47.83% | -31.20% |
| Profit quality | 3.39% | -22.80% | -21.34% | -32.25% | - |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 6.03B | 6.02B | 6.06B | 5.98B | 5.91B |
| Leverage | 1.06 | 1.06 | 1.08 | 1.07 | 1.05 |
| BVPS | 5.54 | 5.54 | 5.47 | 5.42 | 5.48 |
| Turnover | 0.0969 | 0.0947 | 0.0944 | 0.1078 | 0.1306 |
| Cash & STI | 953.57M | 1.92B | 1.11B | 1.98B | 921.19M |
| Inv & Rec | 394.81M | 415.42M | 403.25M | 246.33M | 236.84M |
| LT assets | 533.23M | 526.94M | 513.01M | 514.24M | 505.57M |
| Net debt | -953.57M | -1.92B | -1.11B | -1.98B | -921.19M |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 66.55M | -16.39M | -55.99M | 97.66M | -7.97M |
| Investing CF | -8.92M | 130.29M | -131.85M | -121.33M | -63.25M |
| Financing CF | -20.55M | - | - | 0.0000 | -154.10M |
| Free CF | -1.07B | 743.22M | -1.02B | 772.86M | -937.82M |
| OCF coverage | 208.68% | -138.54% | -42.47% | 43.89% | -4.02% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -11.35M | -11.83M | -131.85M | -222.50M | -44.08M |

## Distribution Plan

**Dividend Yield**: 0.32

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.02CNY | 2025-07-03 | 2025-07-04 | 2025-07-04 |
| Cash Dividend: 
0.15CNY | 2024-07-03 | 2024-07-04 | 2024-07-04 |
| Cash Dividend: 
0.1CNY | 2023-06-27 | 2023-06-28 | 2023-06-28 |